Close-up of two women’s knees with various skin-toned bandages, showcasing inclusivity in care.
Instead of being race based, we need to be race conscious when we practice medicine.
Ted Marcy, retired researcher
FAQ

According to retired physician Ted Marcy, no. Sickle cell anemia is often mislabeled a “Black” disease, but the gene responsible for it is found in populations from regions historically affected by malaria. Likewise, cystic fibrosis is incorrectly stereotyped as a “white” disease. These conditions are tied to ancestry and geography, not socially defined race categories.

Marcy highlights that factors such as socioeconomic status, education, occupation, and income have a stronger influence on disease prevalence than race. For example, individuals with less than a high school education have a higher likelihood of developing diabetes, regardless of their race.

Marcy recommends removing race from the chief complaint or medical history and replacing it with more detailed social and environmental context. For example, instead of labeling a patient as a “30-year-old Black male,” physicians should note relevant factors such as immigration history, socioeconomic situation, or community context. The goal is to focus on real health determinants rather than assumptions associated with racial categories.

Related resources

A female scientist in a lab coat holds a tube, conducting experiments in a laboratory setting.
MAY 07, 2024
Article
Clinical

Diversity at the Start: Best Practices for Clinical Trial Planning

Study sponsors should begin their clinical trial diversity efforts with a fit-for-purpose clinical protocol.

A diverse group of people looking up.
NOV 15, 2023
Article
Clinical

3 Ways Clinical Trial Diversity Can Put Sponsors On Top

Since the FDA’s draft guidance in 2022, the industry has redoubled its efforts to incorporate diversity at pivotal points in the clinical trial process.

global diversity-resource-card-thumbnail
NOV 06, 2023
Article
Clinical

Clinical Trial Diversity on a Global Scale

Reporting clinical trial racial and ethnic data is a crucial step toward clinical trial diversity. But these definitions can be different across countries.

References

1Piel, F., Patil, A., Howes, R. et al. (2010) Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis. Nat Commun. Available from: https://doi.org/10.1038/ncomms1104